Search Results - I. I. Shkrebneva

  • Showing 1 - 10 results of 10
Refine Results
  1. 1
    FIVE-YEAR DYNAMICS OF SECONDARY PREVENTION IN PATIENTS WITH STABLE ANGINA AT SPECIALIZED OUT-PATIENT LEVEL IN MOSCOW (PHARMACOEPIDEMIOLOGY STUDY)

    FIVE-YEAR DYNAMICS OF SECONDARY PREVENTION IN PATIENTS WITH STABLE ANGINA AT SPECIALIZED OUT-PATIENT LEVEL IN MOSCOW (PHARMACOEPIDEMIOLOGY STUDY) by S. В. Fitilev, I. I. Shkrebneva, A. V. Vozzhaev, K. O. Tsukanova

    Published 2018-05-01
    Get full text
    Article

    Save to List
    Saved in:
  2. 2
    SECONDARY PREVENTION OF CARDIOVASCULAR DISEASES AMONG PATIENTS OF DIFFERENT AGE GROUPS WITH A HISTORY OF MYOCARDIAL INFARCTION BY THE EXAMPLE OF OUTPATIENT CARDIOLOGY INSTITUTION

    SECONDARY PREVENTION OF CARDIOVASCULAR DISEASES AMONG PATIENTS OF DIFFERENT AGE GROUPS WITH A HISTORY OF MYOCARDIAL INFARCTION BY THE EXAMPLE OF OUTPATIENT CARDIOLOGY INSTITUTION by S. B. Fitilev, D. A. Dimitrova, I. I. Shkrebneva, A. V. Vozzhaev

    Published 2017-07-01
    Get full text
    Article

    Save to List
    Saved in:
  3. 3
    SECONDARY PREVENTION IN PATIENTS AFTER MYOCARDIAL INFARCTION AT AMBULATORY SPECIALIZED CARDIOLOGY INSTITUTION (PHARMACOEPIDEMIOLOGY STUDY)

    SECONDARY PREVENTION IN PATIENTS AFTER MYOCARDIAL INFARCTION AT AMBULATORY SPECIALIZED CARDIOLOGY INSTITUTION (PHARMACOEPIDEMIOLOGY STUDY) by S. B. Fitilev, I. I. Shkrebneva, A. V. Vozzhaev, D. A. Dimitrova

    Published 2017-05-01
    Get full text
    Article

    Save to List
    Saved in:
  4. 4
    Secondary prevention of coronary heart disease in Moscow-population patients with myocardial infarction

    Secondary prevention of coronary heart disease in Moscow-population patients with myocardial infarction by R. G. Oganov, V. K. Lepakhin, S. B. Fitilev, A. M. Levin, I. I. Shkrebneva, Yu. Yu. Titarova, S. V. Gromakovsaya

    Published 2005-06-01
    Get full text
    Article

    Save to List
    Saved in:
  5. 5
    Quality of ambulatory prevention and treatment of cardiovascular disease and its complications among Туре 2 diabetes mellitus patients

    Quality of ambulatory prevention and treatment of cardiovascular disease and its complications among Туре 2 diabetes mellitus patients by R. G. Oganov, V. K. Lepakhin, S. B. Fitilev, A. M. Levin, I. I. Shkrebneva, Yu. Yu. Titarova, Yu. Yu. Tsiruleva

    Published 2008-12-01
    Get full text
    Article

    Save to List
    Saved in:
  6. 6
    Stable angina pectoris: population trends, diagnostics, secondary prevention, and antianginal therapy

    Stable angina pectoris: population trends, diagnostics, secondary prevention, and antianginal therapy by R. G. Oganov, V. K. Lepakhin, S. B. Fitilev, A. M. Levin, I. I. Shkrebneva, Yu. Yu. Titarova, M. K. Doronkina

    Published 2006-02-01
    Get full text
    Article

    Save to List
    Saved in:
  7. 7
    Assessing the implementation of the recommendations on secondary cardiovascular prevention in patients after myocardial infarction (a pharmaco-epidemiologic study)

    Assessing the implementation of the recommendations on secondary cardiovascular prevention in patients after myocardial infarction (a pharmaco-epidemiologic study) by R. G. Oganov, V. K. Lepakhin, S. B. Fitilev, A. M. Levin, I. I. Shkrebneva, Yu. Yu. Titarova, A. V. Vozzhaev

    Published 2009-08-01
    Get full text
    Article

    Save to List
    Saved in:
  8. 8
    Results of a phase I open randomized comparative crossover clinical trial to assess the safety and pharmacokinetics of Glurazyme® (imiglucerase) in comparison with the reference product in healthy volunteers

    Results of a phase I open randomized comparative crossover clinical trial to assess the safety and pharmacokinetics of Glurazyme® (imiglucerase) in comparison with the reference pr... by S. B. Fitilev, A. V. Vozzhaev, I. I. Shkrebneva, D. A. Kudlay, E. V. Gapchenko, O. A. Markova, A. Yu. Borоzinets, A. A. Kazarov, М. S. Pantyushenko

    Published 2019-12-01
    Get full text
    Article

    Save to List
    Saved in:
  9. 9
    Lipid-lowering therapy in patients with coronary artery disease in primary care practices: what has changed over 7 years?

    Lipid-lowering therapy in patients with coronary artery disease in primary care practices: what has changed over 7 years? by S. K. Zyryanov, S. B. Fitilev, A. V. Vozzhaev, I. I. Shkrebneva, D. A. Klyuev, L. N. Stepanyan, A. A. Danilova, A. T. Tsai, N. N. Landyshev, Ya. G. Voronko

    Published 2020-09-01
    Get full text
    Article

    Save to List
    Saved in:
  10. 10
    Adherence to Medical Treatment in Elderly Patients with Coronary Artery Disease in the Settings of Primary Outpatient Care

    Adherence to Medical Treatment in Elderly Patients with Coronary Artery Disease in the Settings of Primary Outpatient Care by S. K. Zyryanov, S. B. Fitilev, A. V. Vozzhaev, I. I. Shkrebneva, N. N. Shindryaeva, D. A. Klyuev, L. N. Stepanyan, A. M. Lutsenko, A. T. Tsai, A. A. Danilova

    Published 2021-05-01
    Get full text
    Article

    Save to List
    Saved in:

Search Tools: